Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
STTK Shattuck Labs Inc
- Stocks
- Healthcare
- NASDAQ: STTK
Price (delayed)
$0.8537
Market cap
$40.89M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.39
Enterprise value
-$17.74M
Shattuck Labs, Inc. operates as a clinical-stage biotechnology company . The Company focuses on developing a novel class of biologic medicines for the treatment of cancer and autoimmune diseases. Shattuck
Highlights
The debt has declined by 29% year-on-year and by 10% since the previous quarter
Shattuck Labs's EPS has increased by 28% YoY and by 7% from the previous quarter
STTK's revenue has surged by 70% year-on-year but it is down by 19% since the previous quarter
Shattuck Labs's gross profit has surged by 70% YoY but it has decreased by 19% QoQ
The company's equity fell by 48% YoY and by 15% QoQ
Key stats
What are the main financial stats of STTK
Market
Valuations
Earnings
Shares outstanding
47.9M
Market cap
$40.89M
Enterprise value
-$17.74M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.61
Price to sales (P/S)
9.45
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-3.85
Revenue
$4.61M
Gross profit
$4.61M
Operating income
-$74.91M
Net income
-$70.61M
EBIT
-$70.61M
EBITDA
-$66.37M
Free cash flow
-$56.45M
Per share
Balance sheet
Liquidity
EPS
-$1.39
EPS diluted
-$1.39
Free cash flow per share
-$1.11
Book value per share
$1.41
Revenue per share
$0.09
TBVPS
$1.51
Total assets
$77.17M
Total liabilities
$9.58M
Debt
$2.27M
Equity
$67.59M
Working capital
$59.09M
Debt to equity
0.03
Current ratio
9.08
Quick ratio
8.33
Net debt/EBITDA
0.88
Margins
Efficiency
Dividend
EBITDA margin
-1,441%
Gross margin
100%
Net margin
-1,533%
Operating margin
-1,626.4%
Return on assets
-69.1%
Return on equity
-79.7%
Return on invested capital
-185.1%
Return on capital employed
-101.1%
Return on sales
-1,533%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
STTK stock price
How has the Shattuck Labs stock price performed over time
Intraday
-14.63%
1 week
-10.78%
1 month
-25.77%
1 year
-77.23%
YTD
-29.45%
QTD
-10.15%
Financial performance
How have Shattuck Labs's revenue and profit performed over time
Revenue
$4.61M
Gross profit
$4.61M
Operating income
-$74.91M
Net income
-$70.61M
Gross margin
100%
Net margin
-1,533%
STTK's revenue has surged by 70% year-on-year but it is down by 19% since the previous quarter
Shattuck Labs's gross profit has surged by 70% YoY but it has decreased by 19% QoQ
STTK's operating margin has surged by 51% year-on-year but it is down by 15% since the previous quarter
The net margin has surged by 51% year-on-year but it has declined by 16% since the previous quarter
Price vs fundamentals
How does STTK's price correlate with its fundamentals
Growth
What is Shattuck Labs's growth rate over time
Valuation
What is Shattuck Labs stock price valuation
P/E
N/A
P/B
0.61
P/S
9.45
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-3.85
Shattuck Labs's EPS has increased by 28% YoY and by 7% from the previous quarter
The stock's price to book (P/B) is 70% less than its 5-year quarterly average of 2.0 and 49% less than its last 4 quarters average of 1.2
The company's equity fell by 48% YoY and by 15% QoQ
STTK's price to sales (P/S) is 93% lower than its 5-year quarterly average of 142.0 and 61% lower than its last 4 quarters average of 24.1
STTK's revenue has surged by 70% year-on-year but it is down by 19% since the previous quarter
Efficiency
How efficient is Shattuck Labs business performance
Shattuck Labs's ROS has soared by 51% YoY but it has decreased by 16% from the previous quarter
The ROIC is down by 30% YoY and by 23% QoQ
The ROE has declined by 23% year-on-year and by 10% since the previous quarter
STTK's return on assets is down by 20% year-on-year and by 10% since the previous quarter
Dividends
What is STTK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for STTK.
Financial health
How did Shattuck Labs financials performed over time
STTK's total assets is down by 47% year-on-year and by 15% since the previous quarter
STTK's total liabilities is down by 45% year-on-year and by 16% since the previous quarter
The debt is 97% smaller than the equity
The company's debt to equity has surged by 50% YoY
The company's equity fell by 48% YoY and by 15% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.